Maliha Khan

1.5k total citations
56 papers, 991 citations indexed

About

Maliha Khan is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maliha Khan has authored 56 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Genetics and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maliha Khan's work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Maliha Khan is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Maliha Khan collaborates with scholars based in United States, Pakistan and India. Maliha Khan's co-authors include Erkin М Мirrakhimov, Alaa M. Ali, Aram Barbaryan, Rabbia Siddiqi, Frank A. Sinicrope, Harry H. Yoon, Robert B. Diasio, Qian Shi, Tsung‐Teh Wu and Kiran Naqvi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Maliha Khan

53 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maliha Khan United States 16 337 310 230 202 151 56 991
Tao Jin China 18 288 0.9× 289 0.9× 203 0.9× 271 1.3× 78 0.5× 73 1.0k
J Malý Czechia 20 275 0.8× 202 0.7× 166 0.7× 176 0.9× 161 1.1× 124 1.3k
Peter Kozuch United States 19 557 1.7× 263 0.8× 259 1.1× 255 1.3× 176 1.2× 42 1.1k
James Raschko United States 20 416 1.2× 179 0.6× 212 0.9× 223 1.1× 118 0.8× 50 1.1k
Aart Beeker Netherlands 18 452 1.3× 289 0.9× 344 1.5× 126 0.6× 83 0.5× 56 1.1k
Eiko Hasegawa Japan 22 134 0.4× 316 1.0× 299 1.3× 185 0.9× 122 0.8× 163 1.4k
Dipti Gupta United States 19 1.2k 3.5× 393 1.3× 222 1.0× 177 0.9× 204 1.4× 35 2.3k
Rajesh Bandekar United States 19 405 1.2× 377 1.2× 262 1.1× 273 1.4× 221 1.5× 48 1.3k
Abdurrahman Işıkdoğan Türkiye 19 537 1.6× 424 1.4× 204 0.9× 204 1.0× 75 0.5× 146 1.2k
İbrahim Güllü Türkiye 19 453 1.3× 423 1.4× 132 0.6× 261 1.3× 53 0.4× 92 1.2k

Countries citing papers authored by Maliha Khan

Since Specialization
Citations

This map shows the geographic impact of Maliha Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maliha Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maliha Khan more than expected).

Fields of papers citing papers by Maliha Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maliha Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maliha Khan. The network helps show where Maliha Khan may publish in the future.

Co-authorship network of co-authors of Maliha Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Maliha Khan. A scholar is included among the top collaborators of Maliha Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maliha Khan. Maliha Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Maliha, et al.. (2024). A hospital-based study of prostate biopsy results in Indian males. SHILAP Revista de lepidopterología. 13(3). 984–989.
2.
Mayer, Klaus, et al.. (2023). DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models. Disease Models & Mechanisms. 16(9). 3 indexed citations
3.
Khan, Maliha, Felipe Samaniego, Fredrick B. Hagemeister, & Swaminathan P. Iyer. (2021). Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions. Cancers. 13(22). 5627–5627. 1 indexed citations
4.
Khan, Maliha, et al.. (2021). Traumatic Brain Injury-Induced Parkinson's Disease: an Analysis of the Potential Correlation. 1(1). 26–63. 2 indexed citations
5.
Tariq, Saba, et al.. (2020). Venetoclax in the Treatment of Chronic Lymphocytic Leukemia: Evidence, Expectations, and Future Prospects. Cureus. 12(6). e8908–e8908. 9 indexed citations
6.
Beird, Hannah C., Maliha Khan, Rui Wang, et al.. (2019). Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood Cancer Journal. 9(12). 99–99. 24 indexed citations
7.
Khan, Maliha, Naveen Garg, Wei Qiao, et al.. (2018). Comparative outcomes of thrombocytopenic acute leukemic patients with venous thromboembolism at a Comprehensive Cancer Center. Journal of Thrombosis and Thrombolysis. 45(3). 377–385. 7 indexed citations
8.
Khan, Maliha, Rabbia Siddiqi, & Kiran Naqvi. (2018). An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Annals of Hematology. 97(6). 945–953. 37 indexed citations
9.
Khan, Maliha, Pariya Sukhumalchandra, Jason Roszik, et al.. (2018). Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target. Frontiers in Immunology. 8. 1975–1975. 20 indexed citations
10.
Benton, Christopher B., Maliha Khan, Graciela Nogueras González, et al.. (2017). Sequential Stratification Prognostic Score for Patients with Intermediate-Risk Myelodysplastic Syndrome. Blood. 130. 4265–4265. 1 indexed citations
11.
Khan, Maliha, Pariya Sukhumalchandra, Yihua Qiu, et al.. (2017). Cathepsin G Is Expressed By B Cell Acute Lymphoblastic Leukemia and Is an Effective Immunotherapeutic Target. Blood. 130. 1438–1438. 1 indexed citations
12.
Khan, Maliha, Hagop M. Kantarjian, Jing Ning, et al.. (2017). Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia. Blood. 130. 2882–2882. 1 indexed citations
13.
Khan, Maliha, Jörge E. Cortes, Wei Qiao, et al.. (2017). Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 18(1). e19–e25. 12 indexed citations
14.
Khan, Maliha, et al.. (2017). Onychomatricoma in a Patient With Extensive Vitiligo. American Journal of Dermatopathology. 1–1.
15.
Khan, Maliha, Rabbia Siddiqi, & Naseema Gangat. (2017). Therapeutic options for leukemic transformation in patients with myeloproliferative neoplasms. Leukemia Research. 63. 78–84. 10 indexed citations
16.
Khan, Maliha, Rabbia Siddiqi, & Philip A. Thompson. (2017). Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies. Annals of Hematology. 97(1). 1–15. 37 indexed citations
17.
Yoon, Harry H., Mark A. Lewis, Nathan R. Foster, et al.. (2016). Central nervous system relapse in patients with untreated HER2‐positive esophageal or gastroesophageal junction adenocarcinoma. International Journal of Cancer. 139(7). 1626–1631. 10 indexed citations
18.
Мirrakhimov, Erkin М, et al.. (2014). Clostridium perfringens Bacteremia in an 85-Year-Old Diabetic Man. Case Reports in Gastroenterology. 8(3). 404–407. 5 indexed citations
19.
Yoon, Harry H., Qian Shi, William R. Sukov, et al.. (2012). Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas. Clinical Cancer Research. 18(2). 546–554. 116 indexed citations
20.
Yoon, Harry H., Mark A. Lewis, Qian Shi, et al.. (2011). Prognostic Impact of Body Mass Index Stratified by Smoking Status in Patients With Esophageal Adenocarcinoma. Journal of Clinical Oncology. 29(34). 4561–4567. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tao Jin Breakdown of academic impact, for papers by J Malý Breakdown of academic impact, for papers by Peter Kozuch Breakdown of academic impact, for papers by James Raschko Breakdown of academic impact, for papers by Aart Beeker Breakdown of academic impact, for papers by Eiko Hasegawa Breakdown of academic impact, for papers by Dipti Gupta Breakdown of academic impact, for papers by Rajesh Bandekar Breakdown of academic impact, for papers by Abdurrahman Işıkdoğan Breakdown of academic impact, for papers by İbrahim Güllü
Rankless by CCL
2026